REVB Q1 2024 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,262

Operating Income

-$2M

Net Income

-$3M

EPS (Diluted)

$-39.37

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$32,094

Balance Sheet

Total Assets

$15M

Total Liabilities

$5M

Stockholders' Equity

$9M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,262	-$6,263	+0.0%
Operating Income	-$2M	-$2M	-17.4%
Net Income	-$3M	$6M	-143.5%